Predicting response to disease modifying treatment in multiple sclerosis
Multiple sclerosis (MS) is an autoimmune disease affecting the central nervous system (CNS) that most commonly begins with a relapsing-remitting course (RRMS). Many disease modifying treatments now are available, but none have efficacy in all patients, all are expensive and all are associated with p...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
Imperial College London
2017
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.733236 |